vendredi 29 juillet 2016

Morning Break: Drug in the Nose?; Schmacon and Eggs; Genetic Deadend

A protein fragment found in nasal bacteria showed potential as a treatment for multiple types of antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus. (CNN)

Medicare payments for inpatient psychiatric services will increase by 2.2% ($100 million) in fiscal year 2017, according to an announcement from the Centers for Medicare and Medicaid Services.

Love the taste of bacon but not the fat and calories -- or the various turkey-based alternatives? How about Schmacon? (Fox News)

More than a half-century after the "Texas Tower" shootings, the debate continues over laws about gun violence and mental health. (NPR)

Light-intensity exercise and stretching for 10 minutes a day may help relieve menopausal symptoms and depression in middle-age women, according to a small Japanese study. (Reuters)

The earliest known evidence of human cancer emerged from an analysis of hominid fossils 1.7 to 2.0 million years old. (CNN)

Fans of gluten-free diets are saying "I told you so": Non-celiac sensitivity is real. (USA Today)

The data-gathering potential of Fitbit wristbands has attracted the interest of a growing number of health and medical researchers. (Buzzfeed)

Second-hand marijuana smoke caused blood vessel dysfunction in rats that lasted three times as long as effects observed after exposure to tobacco smoke. (New York Daily News)

English Bulldogs have reached a genetic deadend, lacking the diversity to improve the breed and its notorious multitude of health problems. (Gizmodo)

Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.

Let's block ads! (Why?)

Morning Break: Drug in the Nose?; Schmacon and Eggs; Genetic Deadend

Aucun commentaire:

Enregistrer un commentaire